• High Purity Enalapril Maleate API CAS 76095-16-4
  • High Purity Enalapril Maleate API CAS 76095-16-4
  • High Purity Enalapril Maleate API CAS 76095-16-4
  • High Purity Enalapril Maleate API CAS 76095-16-4
  • High Purity Enalapril Maleate API CAS 76095-16-4

High Purity Enalapril Maleate API CAS 76095-16-4

Standard: USP
Transport Package: 25kg/Drum
Specification: 25kg
Trademark: HUAHAI, CHANGZHOU
Origin: China
Samples:
US$ 0/Piece 1 Piece(Min.Order)
| Request Sample
Customization:
Diamond Member Since 2019

Suppliers with verified business licenses

Manufacturer/Factory, Trading Company

Basic Info.

Production Capacity
1000 Mt/Year

Product Description

Enalapril maleate is the second angiotensin converting enzyme inhibitor to reach the marketplace. Like captopril, the first entry in this area, enalapril is useful in the treatment of hypertension and congestive heart failure. It has a longer effective half-life than captopril, allowing once or twice-daily dosing, and appears to have a somewhat lower incidence of side effects.
The principle use of enalapril/enalaprilat in veterinary medicine at present is as a vasodilator in the treatment of heart failure. Recent studies have demonstrated that enalapril, particularly when used in conjunction with furosemide, does improve the quality of life in dogs with heart failure. It is not clear, however, whether it has any significant effect on survival times. It may also be of benefit in treating the effects associated with valvular heart disease (mitral regurgitation) and left to right shunts. It is being explored as adjunctive treatment in chronic renal failure and protein losing nephropathies.
While ACE inhibitors are a mainstay for treating hypertension in humans, they have not been particularly useful in treating hypertension in dogs or cats.
High Purity Enalapril Maleate API CAS 76095-16-4

About Us:
High Purity Enalapril Maleate API CAS 76095-16-4



China Sinopharm International (Shanghai) Co., Ltd. is a comprehensive commercial service enterprise centering international pharmaceutical business.

It is a wholly-owned subsidiary under China Sinopharm International Corporation and is affiliated to China National Pharmaceutical Group Corporation (referred to as "Sinopharm Group"), a Fortune Global 500. Founded in 1985, the company has an net asset of nearly 200 million yuan. It has complete commercial facilities and 23,000 square meters of properties including an office building and shopping malls in Shanghai's West Nanjing Road commercial area and multiple warehouses. International business are carried out based on the platforms of Sinopharm Group and Sinopharm International Pharmaceutical and aims to spread China's high-quality pharmaceutical products and services to the world.

Through close cooperation with major domestic pharmaceutical companies, high-quality pharmaceutical products and overall solutions are provided to overseas customers. We are a well-known pharmaceutical enterprise in China with partners extending to more than 80 countries and regions around the world.

High Purity Enalapril Maleate API CAS 76095-16-4
 

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now